Ticker Short Interest

SCNI Short Interest Intelligence

Scinai Immunotherapeutics Ltd positioning pressure, squeeze risk, bearish conviction, crowding, days to cover, and price-positioning divergence.

Latest settlement 30 Jun 2026 Neutral

Neutral

Bearish Exhaustion Watch

SCNI is classified as Neutral. Latest reported short interest is 26.9K shares; short interest changed -69.8%, price moved -24.2% since the previous report, short interest is in the 14th percentile, and days to cover is in the 71th percentile. Trend context is weak.

Setup Score54/100Neutral
Reported Short Interest26.9K-69.8% vs prior report
Days To Cover1.0071.43 percentile
Price Reaction-24.2%since previous short report
Squeeze Pressure20crowding, trend, and pressure
Bearish Conviction49shorts adding into weakness

Reported Short Interest

2026-03-31 to 2026-06-30

Days To Cover

liquidity pressure

Short Interest Change

report-to-report

Price Context

2026-03-20 to 2026-06-26

Squeeze Radar

20

Elevated short interest becomes most interesting when price strength forces shorts to defend or cover.

Bearish Conviction

49

Rising short interest alongside weak trend can mean the bearish trade is being reinforced, not trapped.

Crowding

40

Latest short interest is 26.9K shares and days to cover is 1.00.

Divergence

54

Short interest fell while price fell. Shorts are covering despite weak price action, which can suggest the easy bearish pressure may be fading.

Report History

SCNI Short Interest Ledger

Most recent first
SettlementShort interestPreviousChangeDays coverAverage volume
30 Jun 2026 26939 89259 -69.8% 1.00 337966
15 Jun 2026 89259 97738 -8.7% 1.00 628506
29 May 2026 97738 157814 -38.1% 1.00 267138
15 May 2026 157814 642343 -75.4% 1.01 156698
30 Apr 2026 642343 72973 780.3% 1.00 18420264
15 Apr 2026 72973 83124 -12.2% 1.00 85584
31 Mar 2026 83124 75161 10.6% 5.61 14806

Short interest is delayed, reported on a periodic schedule, and may be revised. The dashboard is research context only and does not prove real-time short activity.